Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Intracerebral hemorrhage

Preventing recurrence of ICH—should statins be avoided?

Statin use in patients with cerebral hemorrhage may not be without risk. A recent article analyzing existing statin data in a mathematical model suggests that statins might need to be avoided after intracerebral hemorrhage, particularly in patients with a lobar hemorrhage.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Furie, K. L. et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 227–276 (2011).

    Article  PubMed  Google Scholar 

  2. Morgenstern, L. B. et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 41, 2108–2129 (2010).

    Article  PubMed  Google Scholar 

  3. Westover, M. B., Bianchi, M. T., Eckman, M. H. & Greenberg, S. M. Statin use following intracerebral hemorrhage: a decision analysis. Arch. Neurol. doi:10.1001/archneurol.2010.356.

  4. Iso, H., Jacobs, D. R. Jr, Wentworth, D., Neaton, J. D. & Cohen, J. D. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N. Engl. J. Med. 320, 904–910 (1989).

    Article  CAS  PubMed  Google Scholar 

  5. Amarenco, P. & Labreuche, J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 8, 453–463 (2009).

    Article  CAS  PubMed  Google Scholar 

  6. Goldstein, L. B. et al. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 70, 2364–2370 (2008).

    Article  CAS  PubMed  Google Scholar 

  7. Hill, M. D., Silver, F. L., Austin, P. C. & Tu, J. V. Rate of stroke recurrence in patients with primary intracerebral hemorrhage. Stroke 31, 123–127 (2000).

    Article  CAS  PubMed  Google Scholar 

  8. O'Donnell, H. C. et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N. Engl. J. Med. 342, 240–245 (2000).

    Article  CAS  PubMed  Google Scholar 

  9. Bailey, R. D., Hart, R. G., Benavente, O. & Pearce, L. A. Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 56, 773–777 (2001).

    Article  CAS  PubMed  Google Scholar 

  10. Agarwal, V., Phung, O. J., Tongbram, V., Bhardwaj, A. & Coleman, C. I. Statin use and the prevention of venous thromboembolism: a meta-analysis. Int. J. Clin. Pract. 64, 1375–1383 (2010).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koch, S. Preventing recurrence of ICH—should statins be avoided?. Nat Rev Neurol 7, 193–194 (2011). https://doi.org/10.1038/nrneurol.2011.36

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2011.36

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research